| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
|
Gaafar, Rabab M.
|
|
2011
|
47 |
15 |
p. 2331-2340
10 p.
|
artikel
|
| 2 |
Clinical management of primary vulvar cancer
|
Woelber, Linn
|
|
2011
|
47 |
15 |
p. 2315-2321
7 p.
|
artikel
|
| 3 |
Corrigendum to “Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer” [European Journal of Cancer 46 (12) (2010) 2314–2323]
|
Grimm, Martin
|
|
2011
|
47 |
15 |
p. 2373-
1 p.
|
artikel
|
| 4 |
Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients
|
Ali, Arwa M.
|
|
2011
|
47 |
15 |
p. 2265-2272
8 p.
|
artikel
|
| 5 |
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases
|
Ercolani, Giorgio
|
|
2011
|
47 |
15 |
p. 2291-2298
8 p.
|
artikel
|
| 6 |
EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas
|
Nakata, Yoshimi
|
|
2011
|
47 |
15 |
p. 2364-2372
9 p.
|
artikel
|
| 7 |
Hepatic resection for metastatic breast cancer: A systematic review
|
Chua, Terence C.
|
|
2011
|
47 |
15 |
p. 2282-2290
9 p.
|
artikel
|
| 8 |
Higher doses of opioids in patients who need palliative sedation prior to death: Cause or consequence?
|
Oosten, A.W.
|
|
2011
|
47 |
15 |
p. 2341-2346
6 p.
|
artikel
|
| 9 |
Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issues
|
Ferté, Charles
|
|
2011
|
47 |
15 |
p. 2249-2255
7 p.
|
artikel
|
| 10 |
Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma
|
Ng, Kevin Tak-Pan
|
|
2011
|
47 |
15 |
p. 2299-2305
7 p.
|
artikel
|
| 11 |
Pancreatoblastoma: A report from the European cooperative study group for paediatric rare tumours (EXPeRT)
|
Bien, Ewa
|
|
2011
|
47 |
15 |
p. 2347-2352
6 p.
|
artikel
|
| 12 |
Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours
|
Schöffski, Patrick
|
|
2011
|
47 |
15 |
p. 2256-2264
9 p.
|
artikel
|
| 13 |
Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer – EORTC 08062
|
O’Brien, Mary E.R.
|
|
2011
|
47 |
15 |
p. 2322-2330
9 p.
|
artikel
|
| 14 |
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways
|
Feng, Yukuan
|
|
2011
|
47 |
15 |
p. 2353-2363
11 p.
|
artikel
|
| 15 |
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
|
Thuss-Patience, Peter C.
|
|
2011
|
47 |
15 |
p. 2306-2314
9 p.
|
artikel
|
| 16 |
Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer
|
von Minckwitz, Gunter
|
|
2011
|
47 |
15 |
p. 2273-2281
9 p.
|
artikel
|
Tijdschrift beschrijving